A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design.

by Vincent H Tam, Michael Nikolaou
Published 2011-01-01

The impact of serum protein binding on bacterial killing of minocycline

by Li-Xia Xie, Jian Zhou, Kimberly R. Ledesma, Paul R. Merlau, Vincent H. Tam
Published 2020-06-01

MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates

by Andrei Zidaru, Brianna M. Eales, Weiqun Wang, Paul R. Merlau, Todd M. Lasco, Amelia K. Sofjan, Vincent H. Tam
Published 2020-12-01

Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”

by Erik Skoglund, Henrietta Abodakpi, Rafael Rios, Lorena Diaz, Elsa De La Cadena, An Q. Dinh, Javier Ardila, William R. Miller, Jose M. Munita, Cesar A. Arias, Vincent H. Tam, Truc T. Tran
Published 2019-01-01

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways

by Erik Skoglund, Henrietta Abodakpi, Rafael Rios, Lorena Diaz, Elsa De La Cadena, An Q. Dinh, Javier Ardila, William R. Miller, Jose M. Munita, Cesar A. Arias, Vincent H. Tam, Truc T. Tran
Published 2018-01-01

Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections

by Tristan Ferry, Tristan Ferry, Tristan Ferry, Tristan Ferry, Thomas P. Lodise, Jason C. Gallagher, Emmanuel Forestier, Sylvain Goutelle, Sylvain Goutelle, Vincent H. Tam, John F. Mohr, Claire Roubaud-Baudron, Claire Roubaud-Baudron
Published 2020-12-01

Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures

by Vincent H. Tam, Lawrence S. Lee, Tat-Ming Ng, Tze-Peng Lim, Benjamin P.Z. Cherng, Hafeez Adewusi, Kim H. Hee, Ying Ding, Shimin Jasmine Chung, Li-Min Ling, Piotr Chlebicki, Andrea L.H. Kwa, David C. Lye
Published 2020-11-01